The Ministry of Mines and International Energy Agency IEA signed an MoU on Wednesday for cooperation in the area of critical minerals ...

The International Thermonuclear Experimental Reactor (ITER) will be relying on tungsten as its plasma-facing material, but a ...

Plus Therapeutics (PSTV) and SpectronRx announced the signing of a Manufacturing Services Agreement, MSA, for the production of Rhenium ...

Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda ...

德克萨斯州奥斯汀 - 临床阶段制药公司Plus Therapeutics, Inc. (NASDAQ:PSTV)与放射性药物合同开发和制造商SpectronRx合作,生产用于中枢神经系统 (CNS)癌症的先进放射疗法。今天宣布的制造服务协议 (MSA)聚焦于Rhenium (186Re) Obisbemeda,该疗法旨在治疗CNS癌症,包括脑膜转移和复发性胶质母细胞瘤。

Plus Therapeutics has partnered with SpectronRx for the production of Rhenium (186Re) obisbemeda, a targeted radiotherapy for ...

India and Kazakhstan have partnered to establish IREUK Titanium Limited. The joint venture will produce Titanium Slag in ...

Highlights: NW24-27 included a 120m interval grading 0.57g/t Au Eq. and an additional 48m grading 0.35g/t Au Eq., and was successful in testing ...

BWX Technologies, Inc. (NYSE: BWXT) and L3Harris Technologies, Inc. (NYSE: LHX) today announced the signing of a purchase agreement for BWXT to acquire L3Harris' Aerojet Ordnance Tennessee, Inc.

Company will present results from the ReSPECT-LM Phase 1 clinical trial of Rhenium (186Re) Obisbemeda for leptomeningeal metastases (LM) and discuss its plan for continued clinical development ...

Company will present results from the ReSPECT-LM Phase 1 clinical trial of Rhenium (186 Re) Obisbemeda for leptomeningeal metastases (LM) and discuss its plan for continued clinical development ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...